A new, insightful blog post written by Annie Sorbie, Lecturer in Medical Law and Ethics and Zahra Jaffer, who is a PhD candidate at the Mason Institute. The article was published on the Professional Standards Authority blog, and can be accessed through the link.
17 May 2019
10 May 2019
Protecting and promoting: Can regulatory stewardship lead the way in health research? A roundtable discussion at Edinburgh Law School – 29 March 2019
Edward Dove
On 29th
March 2019, a roundtable of research ethics committee (REC) members, research managers,
regulators, patient advocates, and scholars was convened at Edinburgh Law
School to discuss “regulatory
stewardship”, a potentially novel regulatory model of health research
oversight that could improve regulatory interactions among different
stakeholders.
The roundtable
partially built on recent empirical research I conducted on the roles and
practices of NHS RECs in light of recently implemented health research
regulation that explicitly seeks to promote health research in the UK, in part
by streamlining regulation itself. It was unclear to me how these recent
regulatory changes, stressing efficiency and maximisation of UK competitiveness
for health research and maximisation of return from investment in the UK, might
affect the substantive and procedural workings of RECs. It was also unknown
whether or how the modification of research regulation at the level of legal
architecture to promote research—seen, for example, in the Care Act
2014 and in the mandate of the Health
Research Authority (HRA)—might ‘trickle down’ to the day-to-day practices
of RECs.
The research
findings from that empirical investigation can serve as a basis for further
assessments of the relationship between regulatory actors and health research,
thereby opening the potential to inform policy decisions and policy reform.
Indeed, a key aim of this roundtable was to consider a reimagining of
‘regulatory spaces’ in health research to optimise their effectiveness in
delivering productive regulation. Core questions included:
- How might participant protection and research promotion work together in a regulatory framework, if at all?
- Is there a need for a deliberative space within which RECs can both negotiate the risks relevant to a research application and also work with researchers to get to a point where the application can be deemed ethically acceptable?
- What range of actors needs to be involved, with which responsibilities, and towards which ends?
- How might a regulatory deliberative space be protected to capture and promote the fluid, processual nature of REC deliberations and effective health research regulation?
Research from
the University of Edinburgh’s Liminal
Spaces Project suggests that regulatory stewardship involves different
actors—RECs and others involved in the regulation of health research—helping
researchers and sponsors navigate complex regulatory pathways and work through
the thresholds of regulatory approvals. Collective responsibility, as a
component of regulatory stewardship, requires relevant actors to work together
to design and conduct research that is ethical and socially and scientifically
valuable and that ultimately aims to improve human health. This can only be
accomplished if a framework delineates how and when regulators and regulatees
should communicate with one another and makes clear who has what responsibility
and role to be played (if any) at each stage in the research lifecycle.
To this end, in
this roundtable we considered whether a regulatory framework for health
research could identify different kinds of stewards with distinct roles, such
as state stewards, institutional stewards, operational stewards and ethics stewards.
If so, seen in this way, the example of the REC would serve as an illustration
of a potentially much wider contribution to policy, regulation, law, and theory
in the health research context.
Using hexagon
shapes to thematically group responses to several high-level questions posed to
them (see the photo below), roundtable participants helped identify the key
challenges and opportunities associated with regulatory stewardship. For
example, several participants commented on the difficulty in teasing out the
conceptual and practical difference between stewardship and gatekeeping, and considered
whether there are aspects of health research regulation that can be researched
more in-depth to see whether stewardship is observed or can be implemented as a
pilot project. Participants also discussed the link between stewardship and
proportionality: stewardship is partially about streamlining regulatory pathways, helping to avoid
researchers and sponsors and getting bogged down in unnecessary paperwork or
duplicative processes.
Overall,
participants were enthused by the day-long discussion and the potentially
beneficial impact of regulatory stewardship in health research. The immediate
next step for our roundtable group is to construct a short policy brief that will
chart the ways in which regulatory stewardship might be implemented in health
research. Once finalised, as with the forthcoming roundtable report, it will be
publicly disseminated on the Mason
Institute website.
The roundtable
participants acknowledge and thank Wellcome
for funding the roundtable through a Senior Investigator Award entitled
“Confronting the Liminal Spaces of Health Research Regulation” (Award No:
WT103360MA), and the College of Arts, Humanities and Social Sciences at the
University of Edinburgh for supporting the roundtable through funding from a Knowledge
Exchange and Impact Grant.
26 April 2019
The Dissection of Medical Dramas: 19th February 2019
by Zahra Jaffer and Lynn Kennedy
As part of the Festival of Creative Learning (FCL), we hosted the event: The Dissection of Medical Dramas. This interactive workshop used popular
television medical dramas and role-play to identify and discuss the relevant
ethical issues that arise in the medical context. The workshop specifically
focused on issues of consent and the provision of treatment.
Our aim in organising this event was to introduce participants to
issues of medical law and ethics in an interactive and accessible manner. In
the first segment of the event, we used clips from popular television series
such as Grey's Anatomy, Chicago Med and Scrubs to identify and discuss a wide range of issues, such as, the refusal of treatment in late pregnancy, Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) orders and treatment of patients with body dysmorphic disorder. The role-play segment was designed in a
way that required participants to use the skills and information they learned
from the first segment to identify and discuss issues in the role-play segment.
We used television medical dramas and role-play because these mediums are
easily accessible and engaging methods that would allow us to provide a fun and
interactive workshop that would appeal to a wide audience. By using these
mediums, we were celebrating creative learning methods, which was in line with
the spirit of FCL.
There were three key points that we wanted participants to take away
from our event:
1. A competent adult’s right to refuse
medical treatment and the evolving approach to a pregnant woman’s right to
refuse treatment
2. The differences in the approaches to consent
and refusal of treatment in relation to children and mature minors
3. Issues relating to when advance decisions
are upheld
We raised these issues by showing participants relevant clips from
the television series and then we asked their opinions regarding them. We developed
the discussions further by using a number of methods, such as by positing ‘what
if’ questions or by first discussing the legal position on the matter and then asking
participants for their views on the position. The participants were very
engaged and we had some illuminating discussions on the various issues raised,
such as:
1.
Questions
regarding the cessation of treatment versus actively bringing about the death
of the patient in context of withdrawal of life support from a braindead
patient. In turn, this raised questions concerning euthanasia and the
distinction between acts and omissions.
2.
In
relation to a pregnant woman’s right to refuse treatment, a participant
observed that by not giving a pregnant woman the same rights as any other
competent adult to refuse treatment, we would be limiting the woman’s autonomy
and would be attempting to give legal rights to a foetus.
3.
In
relation to the consent to treatment in the cases of children, participants
raised the topical issue of vaccination. One of the participants pointed out that
in Greece, parents have no legal authority to refuse to vaccinate their
children. We were therefore able to learn about the approach of other
jurisdictions on the matter.
We were very pleased to have such a good turnout and a highly
engaged audience that raised thought-provoking discussions. The feedback from
the event was positive, which suggests that the University of Edinburgh student
community has interest in medical law and ethics issues and discussing this in
an interactive, media-supported manner. Since this event was designed to aid
learning in the area of medical law and ethics, we were delighted to see that all
participants who provided feedback gave the event a high score on its
usefulness, and that all stated that they learnt something new and that they
would recommend the event to others. Overall, this has been a wonderful and a highly
rewarding experience.
22 March 2019
Criminalizing medical research fraud: Towards an appropriate legal framework and policy response
Blog post by Gilberto
Leung
When hunting for a topic for
my Dissertation, I went from ‘research ethics’ to ‘research misconduct’ and
eventually cases of medical research fraud that had been treated criminally in
the US. Although there have also been calls for greater criminalization in the
UK, little has been written about how the criminal law may
actually be applied in this context. People were saying we should probably
prosecute researchers such as Wakefield but no one seemed to know or wanted to
know how to go about it. I thought I would examine the knowledge gap.
What I found was that the
Fraud Act 2006 would work very well in dealing with MRF but it casts such a
wide net that many ‘minor’ cases would also be caught. The main issue in front
of me then was about determining the appropriate threshold for prosecution in
something as complex as research fraud. I borrowed the concept of the CPS
policy on assisted suicide and proposed a balance sheet approach. Together with
some amateur work on actus reus and mens rea, I
ended up with a (kind of) legal framework to complement the Fraud Act. In retrospect,
it was a brave/mad move to dive into criminal law just like that but my
supervisor (Professor Graeme Laurie) was extremely helpful and encouraging. Not
sure if the government would listen to me but I am glad that the Dissertation
got a prize and I shall always be grateful for the wonderful learning
experience.
Please, access the article
by following:
View other publications by Gilberto on the
Mason Institute website.
1 March 2019
The sixth annual ‘Great Medico-Legal Debate’: 21 February 2019
After five
successful previous installments, the sixth annual ‘Great Medico-Legal Debate’
was held on 21 February 2019 at the University of Strathclyde. This was the
first time that Strathclyde hosted this annual event, which explores the
arguments on both sides of a current and exciting medical law and ethics topic.
This year’s
debate topic concerned whether the best interests test regarding care of
children should be reformed. As demonstrated by the recent high-profile media
cases of Charlie Gard and Alfie Evans, there have been ongoing questions around
whether the best interests test is fit for purpose in an era of increasing
importance of patient and parental autonomy. Teams were divided into ‘Team for
reform’ and ‘Team against reform’ and a wide audience attended, both from
within and beyond the academy.
In a lively
debate, the two teams considered issues of issues of human rights, medical
ethics, and public policy arising over changes to the judicial test. Audience
members were asked to consider and vote on the issue, after a brief
introduction to the topic by the co-Director of the Mason Institute, Dr Agomoni
Ganguli-Mitra. After arguments took place, audience members were asked to
consider their stance and vote once more on whether the best interests test
should indeed be reformed, in light of the debate that took place. Ultimately,
after a close competition, the invited expert judge, Professor Alison Britton
of Glasgow Caledonian University, decided in favour of ‘Team again reform’.
Audience members’ voting also reflected this view that, while the application
of the best interests test remains vexed, it has the advantage of providing
what Professor Britton described as an ‘end point’. She praised the proposals
for reform that had been argued for including alternative methods for dispute
resolution between doctors and parents and models based on consensus building
rather than a ‘test’. However, as Professor Britton underlined, the need for
decisions to be made promptly and for such decisions to be final is
particularly pressing in the context of a gravely ill child. As such, it was
this consideration that ultimately swayed her finely balanced decision.
After six
events, the ‘Great Medico-Legal Debate’ continues to deliver thoughtful and
in-depth coverage of pressing issues in law and medical ethics, in a creative
and stimulating format. Indeed, Professor Britton remarked upon the exceptional
skills of the debate teams, who not only explored the topic of medical futility
and the best interests test in detail, but also showcased their skills in legal
research and argumentation.
We would like
to say a huge thank you to everyone who made this year’s debate such a success,
including our expert Judge, Professor Britton; our host at Strathclyde, Dr Mary
Neal; the audience members who attended and participated so enthusiastically;
and, most of all, the members of the debate teams, who gave up their own time
to prepare for the debate and delivered such an excellent performance on the
day. We look forward to continuing the seventh installment of the debate in
2020, and further building our medical law and ethics collaboration with
universities across Scotland.
1 February 2019
Social Norms and Health: is a cross-disciplinary vision possible?
Shared ideas about how we should behave have an important influence on
our health. How we maintain our appearance, what we eat, how we move around our
neighbourhoods and what we do to look after ourselves when we are ill, are all
affected by ideas about what is appropriate behaviour. This will
vary considerably depending on, amongst other things, our age, ethnicity,
gender, religion and social status. Such matters of individual
preference are shaped by the ideas of those around us – by our parents,
teachers, friends and neighbours. Such conventions are not formal rules, like
laws or regulations, and so going against them may, at times, result in little
more than social awkwardness, but they nevertheless, shape our behaviour. In
other cases, social norms may be so strongly entrenched that flouting or
ignoring them might come at great cost.
Sociologists and social psychologists often refer to such informal
conventions as ‘social norms’. One sociologist defined a norm as: ‘a
statement specifying how a person is, or persons of a particular sort are,
expected to behave in given circumstances – expected, in the first instance, by
the person that utters the norm. What I expect of you is what you ought to
do.’ [1]
This definition raises questions about the dual aspects of norms. On the
one hand a norm can describe what a particular kind of person might do, an
average response to a specific situation. But norms also have a prescriptive
aspect – a norm is not just an average response, but how a person is supposed to
behave in given circumstances. To make this distinction clear, some authors
reserve the term ‘social norm’ for these prescriptive (‘normative’)
expectations, and use the term ‘descriptive norm’ for other less demanding
requirements.[2] However, whether individuals’
behaviour corresponds to any set of expectations is always an open question
that needs empirical investigation.
As a bioethicist and a sociologist interested in the ethics of public
health, we think that norms may provide additional description and explanation
of people’s health-related behaviours to those used in current health policy.
Neither approaches which explain everything in terms of individual choice
(ignoring the contexts in which those choices are made), nor those that see
individuals as blindly responding to their environments seem entirely
satisfactory. Thinking about the operation of social norms in relation to
health allows us to develop better understandings of people’s behaviour,
and explain how certain behaviours are important to our identities.
In order to develop these ideas further we organised an
interdisciplinary workshop in early September 2019. Our participants included
ethicists, psychologists and social scientists. These researchers presented
their work on topics such as the cost of beauty practices, healthy eating
behaviour, public health campaigns on anti-microbial resistance, toilet use and
vaccination refusal. Over two days we listened to this diverse and very rich
range of collection of case studies and discussed our very different
theoretical approaches to norms. As with many interdisciplinary conversations,
one early challenge was to be clear about the terms we were using – including
what we meant by the term ‘norm’. We also found that some disciplines allow researchers
to develop strongly normative conclusions, whereas in other areas description
is much more highly valued.
At the end of the event we felt like we had only just begun to address a
complex topic and were left with a series of questions for further
investigation. These include:
- Given
that various disciplines define and approach social norms differently, how
do we achieve cross-disciplinary dialogue?
- To
what extent should we take a critical or normative approach to social
norms?
- When
and how do norms change, and can we direct these processes?
- Should
we design public interventions that work with existing norms? Or, should
we also aim at changing them?
- What
happens when norms conflict?
28 November 2018
Mason Institute advises Scottish government on organ donation policy
by Emily
Postan and Annie
Sorbie
On Tuesday 27th November
2018 MI Deputy Directors and policy
portfolio leads, Emily Postan and Annie Sorbie, attended
the Health and Sport Committee to provide
evidence on our MI consultation response to the Human Tissue (Authorisation) (Scotland) Bill. This
Bill makes provision for the authorisation of the removal and use of parts of
the body of a deceased person for transplantation and other
purposes. Significantly, it proposes that Scotland move from the
current ‘opt-in’ system, in which an individual’s organs may be used for
transplantation only when they (or, after their death, a close relative) have
explicitly authorised this, to one of ‘deemed authorisation’. Under the
proposed law, adults who have not formally registered their wishes will be
deemed to have authorised the use of their organs for transplant purposes, with
some exceptions for particular groups of persons and types of body parts. Under
the new law the option to ‘opt-out’ of donation will be placed on a statutory
footing (as will a third option of explicitly ‘opting in’).
In our MI consultation response we had
outlined our broad support for the policy objectives of the Bill, but
emphasised that legislation is but one step towards improving donation and
transplantation rates, and that a holistic package of regulatory, social and ethical
measures are necessary to secure these objectives. These include the need for
far-reaching public information programmes, training and resourcing of
transplant coordination professionals, and comprehensive evidence-gathering
about the impacts of the legislative changes.
Also giving evidence in this meeting of
the Committee were Professor Alison Britton, Professor of Healthcare and
Medical Law and Convenor of the Health and Medical Law Sub Committee for the
Law Society of Scotland, and Dr Calum MacKellar, Director of Research at the
Scottish Council on Human Bioethics.
In her oral evidence Dr Postan was able
to answer the Committee’s questions on several issues.
The Committee was interested in the
question of how the respective interests would be weighed and met under the new
legislation, particularly whether relatives’ wishes might, in practice, often
override those of deceased persons as they do under the current law. Under the
proposed law, relatives will not have a legal entitlement to override the
express or deemed wishes of the deceased, but if they present evidence that the
most recent views of the deceased differ from those registered or deemed to
hold, then this will be taken into account. Dr Postan suggested that providing
guidance to transplant coordinators, to support them in judging what counts as
reasonable evidence of changed wishes, could be of great value and noted the
risks of sending mixed messages to family members about their degree of their
involvement in decision-making when the deceased person’s wishes are not
ambiguous. Along with the other witnesses she emphasised the need for a
far-reaching communications and training strategy to support the changes in
culture and expectations that will be needed if the new law is to function as
intended.
Dr Postan responded to the Committee’s
questions about the protection of adults lacking capacity under the proposed
law by suggesting that as currently drafted the law perhaps reflects too binary
a conception of capacity and that it ought to be interpreted in a way that is
consistent with the recognition under the Adults with Incapacity (Scotland) Act
2000 that capacity can fluctuate and should be assessed in a context specific
manner and that individuals should be supported to make decisions when they
can.
The Committee reflected concerns of
some consultees about the ethics and legality of also making pre-death
procedures (preparatory to donation) subject to ‘deemed authorisation’. Dr
Postan responded that even though these procedures might not be for the
clinical benefit of the patient, as long as they are minimally invasive and do
not cause discomfort or hasten death, they may be seen as being in the best
interests of the patient (and therefore both lawful and ethical), insofar as
they are a necessary and anticipated part of fulfilling their wishes to act as
donors.
This work exemplifies
the MI’s commitment to bringing our interdisciplinary approach and research to
bear on practical questions. If you would like to bring a consultation to our
attention or to discuss the possibility of working with us on a particular
policy matter, please get in touch with us by emailing Emily
Postan and Annie Sorbie.
Subscribe to:
Posts (Atom)
